Medtech innovation cycles are evermore complex to manage. Traditional distribution channels are not adaptive enough for this complexity. Above all, patients deserve to benefit from the best solutions.
 
						Developed and manage a high-performing portfolio in aortic, structural heart, and interventional cardiology, consistently delivering double-digit growth over the past 10+ years.












Commitment, reliability in the cardiovascular field for successful market launch and growth. Network in 2025.
Interventional 
 Cardiologists
Interventional 
 Radiologists
Vascular 
 Surgeons
Interventional 
 Neuroradiologists
 
						




















